NCT00149929View on ClinicalTrials.gov

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Renal Transplant
Interventions
DRUG

Mycophenolate sodium (enteric coated)

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY